Founder Greg Sullivan will transition into the role of Chief Technology Officer to focus on advancing MMS’s technology platform, next-generation product development, and clinical evidence initiatives.
July 22, 2025
Founder Greg Sullivan will transition into the role of Chief Technology Officer to focus on advancing MMS’s technology platform, next-generation product development, and clinical evidence initiatives.